No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms

Sofie Mohlin, Kristoffer Von Stedingk, Alexander Pietras, Sven Påhlman

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)E10856-E10858
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number51
Publication statusPublished - 2017 Dec 19

Subject classification (UKÄ)

  • Cancer and Oncology

Cite this